Veracyte zeros in on diagnostic tests, seeks $75 million IPO

Veracyte Inc. is building a business with a thyroid tests that may reduce the number of surgeries, but the success of its IPO plans rest in its ability to expand its diagnostics franchise...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.